
Heska Corporation HSKA
Quarterly report 2023-Q1
added 05-05-2023
Heska Corporation Total Inventories 2011-2025 | HSKA
Annual Total Inventories Heska Corporation
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 60 M | 49.4 M | 40 M | 26.6 M | 25.1 M | 32.6 M | 20.4 M | 16.1 M | 12.7 M | 11.7 M | 12.5 M | 12.4 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 60 M | 11.7 M | 26.6 M |
Quarterly Total Inventories Heska Corporation
| 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 64.2 M | 60 M | 57.5 M | 55.8 M | 55.2 M | 49.4 M | 45 M | 41.2 M | 39.4 M | 40 M | 40 M | 40 M | 40 M | 26.6 M | 26.6 M | 26.6 M | 26.6 M | 25.1 M | 25.1 M | 25.1 M | 25.1 M | 32.6 M | 32.6 M | 32.6 M | 32.6 M | 20.4 M | 20.4 M | 20.4 M | 20.4 M | 16.1 M | 16.1 M | 16.1 M | 16.1 M | 12.7 M | 12.7 M | 12.7 M | 12.7 M | 11.7 M | 11.7 M | 11.7 M | 11.7 M | 12.5 M | 12.5 M | 12.5 M | 12.5 M | 12.4 M | 12.4 M | 12.4 M | 12.4 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 64.2 M | 11.7 M | 26.7 M |
Total Inventories of other stocks in the Diagnostics research industry
| Issuer | Total Inventories | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Accelerate Diagnostics
AXDX
|
5.19 M | - | -61.36 % | $ 2.46 M | ||
|
Burning Rock Biotech Limited
BNR
|
123 M | $ 20.31 | -5.8 % | $ 221 M | ||
|
Co-Diagnostics
CODX
|
1.66 M | $ 0.23 | -4.17 % | $ 6.75 M | ||
|
Biocept
BIOC
|
757 K | - | -13.05 % | $ 7.29 M | ||
|
Chembio Diagnostics
CEMI
|
7.72 M | - | 0.22 % | $ 16.8 M | ||
|
Castle Biosciences
CSTL
|
8.14 M | $ 39.2 | -0.49 % | $ 1.09 B | ||
|
Danaher Corporation
DHR
|
2.33 B | $ 230.87 | 0.23 % | $ 169 B | ||
|
DarioHealth Corp.
DRIO
|
5.06 M | $ 10.36 | 3.19 % | $ 294 M | ||
|
BioNano Genomics
BNGO
|
13.3 M | $ 1.51 | -0.9 % | $ 1.92 M | ||
|
Exact Sciences Corporation
EXAS
|
162 M | $ 101.86 | 0.28 % | $ 18.9 B | ||
|
DexCom
DXCM
|
560 M | $ 67.65 | 0.12 % | $ 26.1 B | ||
|
Enzo Biochem
ENZ
|
6.83 M | - | -8.98 % | $ 14.8 K | ||
|
Global Cord Blood Corporation
CO
|
45.9 M | - | - | $ 399 M | ||
|
DermTech
DMTK
|
1 M | - | -11.32 % | $ 2.94 M | ||
|
CareDx, Inc
CDNA
|
19.5 M | $ 19.19 | -1.49 % | $ 1.03 B | ||
|
HTG Molecular Diagnostics
HTGM
|
909 K | - | -20.0 % | $ 1.06 M | ||
|
Guardant Health
GH
|
71.1 M | $ 100.93 | -1.99 % | $ 12.4 B | ||
|
Aspira Women's Health
AWH
|
316 K | - | -6.19 % | $ 10.5 M | ||
|
Myriad Genetics
MYGN
|
27.5 M | $ 6.32 | -2.55 % | $ 573 M | ||
|
ENDRA Life Sciences
NDRA
|
2.62 M | $ 4.75 | -4.81 % | $ 2.55 M | ||
|
Neogen Corporation
NEOG
|
191 M | $ 7.2 | 0.98 % | $ 1.56 B | ||
|
Illumina
ILMN
|
547 M | $ 134.56 | -0.29 % | $ 21.4 B | ||
|
Charles River Laboratories International
CRL
|
279 M | $ 203.33 | -0.11 % | $ 10.4 B | ||
|
Quest Diagnostics Incorporated
DGX
|
188 M | $ 175.36 | -0.34 % | $ 19.5 B | ||
|
Motus GI Holdings
MOTS
|
496 K | - | -34.28 % | $ 263 K | ||
|
Laboratory Corporation of America Holdings
LH
|
493 M | $ 252.95 | -0.4 % | $ 21.2 B | ||
|
ICON Public Limited Company
ICLR
|
2.3 M | $ 182.75 | -0.05 % | $ 15.1 B | ||
|
IDEXX Laboratories
IDXX
|
382 M | $ 685.99 | -0.36 % | $ 56.6 B | ||
|
Lantheus Holdings
LNTH
|
68 M | $ 67.0 | 0.43 % | $ 4.64 B | ||
|
Mettler-Toledo International
MTD
|
342 M | $ 1 419.41 | -0.06 % | $ 30.1 B | ||
|
Agilent Technologies
A
|
830 M | $ 138.09 | -0.22 % | $ 42 B | ||
|
Biomerica
BMRA
|
1.49 M | $ 2.6 | -3.7 % | $ 5.97 M |